| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Werewolf Therapeutics, Inc. (HOWL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 30 sells. HOWL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 6.24M | $3.87M | - | |
| 10% | 4.78M | $2.97M | - | |
| 10% | 4.78M | $2.97M | - | |
| Dir | 1.68M | $1.04M | -480,530 | |
| Dir | 27.0K | $16.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | Evnin Luke55 | Director | Sell | 274,619 | $0.72 | $198,309.62 | -5.0% | - | - | |
| Apr 29, 2026 | Evnin Luke55 | Director | Sell | 205,911 | $0.75 | $154,525.47 | -3.3% | - | - | |
| Jan 16, 2026 | Evnin Luke55 | Director | Sell | 38,782 | $0.54 | $20,942.28 | -1.8% | - | - | |
| Jan 15, 2026 | Evnin Luke55 | Director | Sell | 111,227 | $0.56 | $61,787.17 | -1.6% | +54.1% | - | |
| Jan 12, 2026 | Evnin Luke55 | Director | Sell | 91,374 | $0.59 | $53,533.26 | -1.3% | +47.8% | - | |
| Jan 7, 2026 | Evnin Luke55 | Director | Sell | 71,054 | $0.65 | $45,882.17 | -1.0% | +55.9% | - | |
| Jan 2, 2026 | Evnin Luke55 | Director | Sell | 78,377 | $0.62 | $48,430.95 | -1.0% | +56.6% | - | |
| Dec 29, 2025 | Evnin Luke55 | Director | Sell | 291,283 | $0.64 | $185,220.79 | -2.1% | +28.3% | - | |
| Dec 17, 2025 | Evnin Luke55 | Director | Sell | 48,171 | $1.08 | $51,950.82 | -0.6% | -18.7% | - | |
| Dec 12, 2025 | Evnin Luke55 | Director | Sell | 82,971 | $1.07 | $88,586.51 | -0.9% | -24.9% | - |